Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7,242.36% | -236.75% | -433.02% | -758.51% | -94.86% |
| Total Depreciation and Amortization | 11.73% | -2.70% | 66.11% | 3.11% | -0.50% |
| Total Amortization of Deferred Charges | -- | -- | -75.22% | -- | -- |
| Total Other Non-Cash Items | 18.56% | 8.98% | 7.01% | 131.38% | -13.95% |
| Change in Net Operating Assets | 31.08% | -179.37% | 344.16% | -267.09% | 203.59% |
| Cash from Operations | -131.95% | -429.63% | -89.14% | -235.56% | 11.26% |
| Capital Expenditure | 6.32% | 15.78% | 33.45% | 73.70% | 63.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 6.32% | 15.78% | 33.45% | 80.80% | 63.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 87.75% | 6.15% | 6.28% | 82.51% | -2,670.12% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | 665.97% |
| Repurchase of Common Stock | 74.80% | 66.03% | 33.87% | -64.02% | -88.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,084.15% | 51.79% | 121.32% | 32.07% | 67.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -240.36% | -3,674.88% | -92.41% | -3,648.94% | 640.36% |